Clinical Cancer Research, Vol 2, Issue 7 1221-1229, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction

NS Prabhu, MV Blagosklonny, YX Zeng, GS Wu, T Waldman and WS El-Deiry
Howard Hughes Medical Institute, Laboratory of Molecular Oncology, Chicago, Illinois, USA.

p53 tumor suppression is deficient in the majority of human cancers. Efforts to understand this pathway have identified cyclin-dependent kinase (CDK) inhibitors and suggested a potential for their replacement in human cancer. In the present studies, expression of a C-terminal deletion mutant of the human p21(WAF1/CIP1) CDK inhibitor completely suppressed the growth of colon cancer cells, whereas full-length p21 only partially suppressed growth. We prepared a replication-deficient adenoviral recombinant which expresses the p21 C-terminal mutant (Ad-WAF1-341) and compared its tumor suppressive abilities with Ad-p53 and Ad-LacZ. Ad-WAF1-341- and Ad-p53-infected cancer cells, but not Ad-LacZ-infected cancer cells, expressed a nuclear protein recognized by anti-p21 antibody and were deficient in cell cycle progression. The exogenous p21 mutant interacted with CDK2 but not proliferating cell nuclear antigen following infection of p21-/- cancer cells. Ad-WAF1-341 was more potent than Ad-p53 in inhibiting DNA synthesis in human papillomavirus 16 E6-expressing cancer cells. Most importantly, the Ad-WAF1-341-infected E6-expressing cells died, whereas most of the Ad-p53-infected cells continued to proliferate. Endonucleolytic cleavage of DNA was observed in Ad-WAF1-341-infected cancer cells. These observations suggest that Ad-WAF1-341 should be evaluated in the treatment of human papillomavirus-associated neoplasia and other neoplasias resistant to p53.

This article has been cited by other articles:

				N. G. Nagl Jr., A. Patsialou, D. S. Haines, P. B. Dallas, G. R. Beck Jr., and E. Moran The p270 (ARID1A/SMARCF1) Subunit of Mammalian SWI/SNF-Related Complexes Is Essential for Normal Cell Cycle Arrest Cancer Res., October 15, 2005; 65(20): 9236 - 9244. [Abstract] [Full Text] [PDF]

				M. S. Ricci, Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity Mol. Cell. Biol., October 1, 2004; 24(19): 8541 - 8555. [Abstract] [Full Text] [PDF]

				P. M. Price, R. L. Safirstein, and J. Megyesi Protection of renal cells from cisplatin toxicity by cell cycle inhibitors Am J Physiol Renal Physiol, February 1, 2004; 286(2): F378 - F384. [Abstract] [Full Text] [PDF]

				Q. Wu, P. Kirschmeier, T. Hockenberry, T.-Y. Yang, D. L. Brassard, L. Wang, T. McClanahan, S. Black, G. Rizzi, M. L. Musco, et al. Transcriptional Regulation during p21WAF1/CIP1-induced Apoptosis in Human Ovarian Cancer Cells J. Biol. Chem., September 20, 2002; 277(39): 36329 - 36337. [Abstract] [Full Text] [PDF]

				B. J. Kim, M.-S. Kim, K.-B. Kim, K.-W. Kim, Y.-M. Hong, I.-K. Kim, H.-W. Lee, and Y.-K. Jung Sensitizing effects of cadmium on TNF-{alpha}- and TRAIL-mediated apoptosis of NIH3T3 cells with distinct expression patterns of p53 Carcinogenesis, September 1, 2002; 23(9): 1411 - 1417. [Abstract] [Full Text] [PDF]

				Y. B. Dong, H. L. Yang, M. J. Elliott, and K. M. McMasters Adenovirus-mediated E2F-1 Gene Transfer Sensitizes Melanoma Cells to Apoptosis Induced by Topoisomerase II Inhibitors Cancer Res., March 1, 2002; 62(6): 1776 - 1783. [Abstract] [Full Text] [PDF]

				K. A. Moffatt, W. U. Johannes, T. E. Hedlund, and G. J. Miller Growth Inhibitory Effects of 1{alpha}, 25-Dihydroxyvitamin D3 Are Mediated by Increased Levels of p21 in the Prostatic Carcinoma Cell Line ALVA-31 Cancer Res., October 1, 2001; 61(19): 7122 - 7129. [Abstract] [Full Text] [PDF]

				G. CONDORELLI, J. K. AYCOCK, G. FRATI, and C. NAPOLI Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice FASEB J, October 1, 2001; 15(12): 2162 - 2170. [Abstract] [Full Text] [PDF]

				A. Divan, J. Lawry, I. R. Dunsmore, M. A. Parsons, and J. A. Royds p53 and p21waf-1 Expression Correlates with Apoptosis or Cell Survival in Poorly Differentiated, but not Well-Differentiated, Retinoblastomas Cancer Res., April 1, 2001; 61(7): 3157 - 3163. [Abstract] [Full Text]

				K. O. Mitchell, M. S. Ricci, T. Miyashita, D. T. Dicker, Z. Jin, J. C. Reed, and W. S. El-Deiry Bax Is a Transcriptional Target and Mediator of c-Myc-induced Apoptosis Cancer Res., November 1, 2000; 60(22): 6318 - 6325. [Abstract] [Full Text]

				F. Chai, A. Evdokiou, G.P. Young, and P.D. Zalewski Involvement of p21Waf1/Cip1 and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate Carcinogenesis, January 1, 2000; 21(1): 7 - 14. [Abstract] [Full Text] [PDF]

				K. O. Mitchell and W. S. El-Deiry Overexpression of c-Myc Inhibits p21WAF1/CIP1 Expression and Induces S-Phase Entry in 12-O-Tetradecanoylphorbol-13-acetate (TPA)-sensitive Human Cancer Cells Cell Growth Differ., April 1, 1999; 10(4): 223 - 230. [Abstract] [Full Text]

				F. Di Cunto, G. Topley, E. Calautti, J. Hsiao, L. Ong, P. K. Seth, and G. P. Dotto Inhibitory Function of p21Cip1/WAF1 in Differentiation of Primary Mouse Keratinocytes Independent of Cell Cycle Control Science, May 15, 1998; 280(5366): 1069 - 1072. [Abstract] [Full Text]

				N. J. Donato and M. Perez Tumor Necrosis Factor-induced Apoptosis Stimulates p53 Accumulation and p21WAF1 Proteolysis in ME-180 Cells J. Biol. Chem., February 27, 1998; 273(9): 5067 - 5072. [Abstract] [Full Text] [PDF]